Health | Politics
Witness list for Indian Affairs Committee hearing on diabetes
The Senate Indian Affairs Committee will hold a business meeting and oversight hearing this Wednesday, June 30.

The hearing will focus on diabetes. The witness list follows:
Panel # 1
Dr. Judith Fradkin
Director, Division of Diabetes, Endocrinology and Metabolic Diseases, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health

Panel # 2
Mr. Wes Studi
Professional Actor and Native American health advocate

Mr. Gary Hall
Olympian Swimmer, 10-time Olympic medalist

Dr, Melvina McCabe, MD
President, Association of American Indian Physicians

Mr. Caitlin Baker
Muscogee Creek Nation, Founder of Caitlinb

Committee Notices:
BUSINESS MEETING on pending committee issues (June 30, 2010)
OVERSIGHT HEARING on A Way Out of the Diabetes Crisis in Indian Country and Beyond (June 30, 2010)

Related Stories:
Series: Bad River Band suffers from very high rate of diabetes (6/25)
Senate Indian Affairs Committee meeting, hearing on June 30 (06/24)
Indian Country takes aim at alarming rate of Type 2 diabetes (6/24)

This story is tagged under:
111th
diabetes
scia
Search
Trending in News
1 White House Council on Native American Affairs meets quick demise under Donald Trump
2 'A process of reconnecting': Young Lakota actor finds ways to stay tied to tribal culture
3 Jenni Monet: Bureau of Indian Affairs officer on leave after fatal shooting of Brandon Laducer
4 'A disgraceful insult': Joe Biden campaign calls out Navajo leader for Republican speech
5 Kaiser Health News: Sisters from Navajo Nation died after helping coronavirus patients
More Stories
Opinion: Recognize achievements of Maine Native Americans
Supreme Court dismisses petition in Cobell accounting appeal
Share this Story!

You are enjoying stories from the Indianz.Com Archive, a collection dating back to 2000. Some outgoing links may no longer work due to age.

All stories in the Indianz.Com Archive are available for publishing via Creative Commons License: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)